Iranian Red Crescent Medical Journal

Published by: Kowsar

Treatment of Metabolic Acidosis in Altering Inflammatory Biomarkers in Renal Transplant Recipients; A Randomized Clinical Trial

Mohammad Fathi 1 , Nilofar Massoudi 2 , * , Amirhesam Alirezaei 3 and Mahmood Bakhtiyari 4
Authors Information
1 Critical Care Quality Improvement Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Clinical Research and Development Unit, Shahid Modarres Hospital, Department of Anesthesiology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Clinical Research Development Center, Shahid Modarres Hospital, Department of Nephrology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Department of Community Medicine, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
Article information
  • Iranian Red Crescent Medical Journal: October 2018, 20 (10); e68102
  • Published Online: October 20, 2018
  • Article Type: Research Article
  • Received: February 27, 2018
  • Revised: September 1, 2018
  • Accepted: September 2, 2018
  • DOI: 10.5812/ircmj.68102

To Cite: Fathi M, Massoudi N, Alirezaei A, Bakhtiyari M. Treatment of Metabolic Acidosis in Altering Inflammatory Biomarkers in Renal Transplant Recipients; A Randomized Clinical Trial, Iran Red Crescent Med J. 2018 ; 20(10):e68102. doi: 10.5812/ircmj.68102.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
References
  • 1. Baloch MH, Shams N, Mahmood N, Zahoor W, Seetlani NK, Bashir F. End stage renal disease: Hematological profile in geriatric end stage renal disease hemodialysis cases. Professional Med J. 2018;25(5):728-34.
  • 2. Li PK, Chow KM, Van de Luijtgaarden MW, Johnson DW, Jager KJ, Mehrotra R, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13(2):90-103. doi: 10.1038/nrneph.2016.181. [PubMed: 28029154].
  • 3. Crews DC, Banerjee T, Wesson DE, Morgenstern H, Saran R, Burrows NR, et al. Race/ethnicity, dietary acid load, and risk of end-stage renal disease among US adults with chronic kidney disease. Am J Nephrol. 2018;47(3):174-81. doi: 10.1159/000487715. [PubMed: 29525790]. [PubMed Central: PMC5906156].
  • 4. Lobo DJ, Prabhu R, Kamath A, Bhat V. Current status of end stage renal disease in india – a narrative review. Int J Nurs Educ. 2017;9(3):103-8. doi: 10.5958/0974-9357.2017.00078.2.
  • 5. Calia R, Lai C, Aceto P, Luciani M, Camardese G, Lai S, et al. Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: Preliminary results. Ren Fail. 2015;37(4):678-80. doi: 10.3109/0886022X.2015.1010989. [PubMed: 25687387].
  • 6. Mousavi SS, Soleimani A, Mousavi MB. Epidemiology of end-stage renal disease in Iran: A review article. Saudi J Kidney Dis Transpl. 2014;25(3):697-702. doi: 10.4103/1319-2442.132242. [PubMed: 24821181].
  • 7. Haghighi AN, Broumand B, D'Amico M, Locatelli F, Ritz E. The epidemiology of end-stage renal disease in Iran in an international perspective. Nephrol Dial Transplant. 2002;17(1):28-32. doi: 10.1093/ndt/17.1.28. [PubMed: 11773458].
  • 8. Shetty AA, Wertheim JA, Butt Z. Health-related quality of life outcomes after kidney transplantation. Kidney transplantation, bioengineering and regeneration. Elsevier; 2017. p. 699-708. doi: 10.1016/b978-0-12-801734-0.00050-3.
  • 9. Klaassen G, Zelle DM, Navis GJ, Dijkema D, Bemelman FJ, Bakker SJL, et al. Lifestyle intervention to improve quality of life and prevent weight gain after renal transplantation: Design of the Active Care after Transplantation (ACT) randomized controlled trial. BMC Nephrol. 2017;18(1):296. doi: 10.1186/s12882-017-0709-0. [PubMed: 28915863]. [PubMed Central: PMC5599936].
  • 10. DuBose TD. Etiologic causes of metabolic acidosis II: Normal anion gap acidoses. Metabolic acidosis. Springer; 2016. p. 27-38. doi: 10.1007/978-1-4939-3463-8_4.
  • 11. Kraut JA, Madias NE. Adverse effects of the metabolic acidosis of chronic kidney disease. Adv Chronic Kidney Dis. 2017;24(5):289-97. doi: 10.1053/j.ackd.2017.06.005. [PubMed: 29031355].
  • 12. Kraut JA, Madias NE. Metabolic Acidosis of CKD: An Update. Am J Kidney Dis. 2016;67(2):307-17. doi: 10.1053/j.ajkd.2015.08.028. [PubMed: 26477665].
  • 13. Ambuhl PM. Posttransplant metabolic acidosis: A neglected factor in renal transplantation? Curr Opin Nephrol Hypertens. 2007;16(4):379-87. doi: 10.1097/MNH.0b013e3281bd8860. [PubMed: 17565282].
  • 14. Roderick P, Willis NS, Blakeley S, Jones C, Tomson C. Correction of chronic metabolic acidosis for chronic kidney disease patients. Cochrane Database Syst Rev. 2007;(1). CD001890. doi: 10.1002/14651858.CD001890.pub3. [PubMed: 17253467].
  • 15. van den Berg E, Engberink MF, Brink EJ, van Baak MA, Joosten MM, Gans RO, et al. Dietary acid load and metabolic acidosis in renal transplant recipients. Clin J Am Soc Nephrol. 2012;7(11):1811-8. doi: 10.2215/CJN.04590512. [PubMed: 22935845]. [PubMed Central: PMC3488949].
  • 16. Heaf J, Tvedegaard E, Kanstrup IL, Fogh-Andersen N. Bone loss after renal transplantation: Role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant. 2000;14(5):457-63. doi: 10.1034/j.1399-0012.2000.140503.x. [PubMed: 11048990].
  • 17. Etezadi F, Pourfakhr P, Mojtahedzade M, Najafi A, Moharari RS, Yarandi KK, et al. Effects of tight versus non tight control of metabolic acidosis on early renal function after kidney transplantation. Daru. 2012;20(1):36. doi: 10.1186/2008-2231-20-36. [PubMed: 23351673]. [PubMed Central: PMC3555784].
  • 18. Kim SY, Huh KH, Lee JR, Kim SH, Jeong SH, Choi YS. Comparison of the effects of normal saline versus Plasmalyte on acid-base balance during living donor kidney transplantation using the Stewart and base excess methods. Transplant Proc. 2013;45(6):2191-6. doi: 10.1016/j.transproceed.2013.02.124. [PubMed: 23953528].
  • 19. Hadimioglu N, Saadawy I, Saglam T, Ertug Z, Dinckan A. The effect of different crystalloid solutions on acid-base balance and early kidney function after kidney transplantation. Anesth Analg. 2008;107(1):264-9. doi: 10.1213/ane.0b013e3181732d64. [PubMed: 18635497].
  • 20. Yasuda K, Hayashi M, Murayama M, Yamakita N. Acidosis-induced hypochloremic alkalosis in diabetic ketoacidosis confirmed by the modified base excess method. J Clin Endocrinol Metab. 2016;101(6):2390-5. doi: 10.1210/jc.2016-1324. [PubMed: 27050945].
  • 21. Lin SH, Lin YF, Chin HM, Wu CC. Must metabolic acidosis be associated with malnutrition in haemodialysed patients? Nephrol Dial Transplant. 2002;17(11):2006-10. doi: 10.1093/ndt/17.11.2006. [PubMed: 12401862].
  • 22. Dos Santos MP, Batistela E, Pereira MP, Paula-Gomes S, Zanon NM, Kettelhut Ido C, et al. Higher insulin sensitivity in EDL muscle of rats fed a low-protein, high-carbohydrate diet inhibits the caspase-3 and ubiquitin-proteasome proteolytic systems but does not increase protein synthesis. J Nutr Biochem. 2016;34:89-98. doi: 10.1016/j.jnutbio.2016.04.008. [PubMed: 27239756].
  • 23. Donate-Correa J, Martin-Nunez E, Muros-de-Fuentes M, Mora-Fernandez C, Navarro-Gonzalez JF. Inflammatory cytokines in diabetic nephropathy. J Diabetes Res. 2015;2015:948417. doi: 10.1155/2015/948417. [PubMed: 25785280]. [PubMed Central: PMC4345080].
  • 24. Sanchez-Fructuoso AI, Perez-Flores I, Valero R, Moreno MA, Fernandez-Arquero M, Urcelay E, et al. The polymorphism -308G/A of tumor necrosis factor-alpha gene modulates the effect of immunosuppressive treatment in first kidney transplant subjects who suffer an acute rejection. J Immunol Res. 2016;2016:2197595. doi: 10.1155/2016/2197595. [PubMed: 27777962]. [PubMed Central: PMC5061951].
  • 25. Haase M, Haase-Fielitz A, Bellomo R, Devarajan P, Story D, Matalanis G, et al. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: A pilot double-blind, randomized controlled trial. Crit Care Med. 2009;37(1):39-47. doi: 10.1097/CCM.0b013e318193216f. [PubMed: 19112278].
  • 26. Potura E, Lindner G, Biesenbach P, Funk GC, Reiterer C, Kabon B, et al. An acetate-buffered balanced crystalloid versus 0.9% saline in patients with end-stage renal disease undergoing cadaveric renal transplantation: A prospective randomized controlled trial. Anesth Analg. 2015;120(1):123-9. doi: 10.1213/ANE.0000000000000419. [PubMed: 25185593].
  • 27. Ayebale ET, Kwizera A, Mijumbi C, Kizito S, Roche AM. Ringer's lactate versus normal saline in urgent cesarean delivery in a resource-limited setting: A pragmatic clinical trial. Anesth Analg. 2017;125(2):533-9. doi: 10.1213/ANE.0000000000002229. [PubMed: 28682955].
  • 28. Boldt J, Haisch G, Suttner S, Kumle B, Schellhase F. Are lactated Ringer's solution and normal saline solution equal with regard to coagulation? Anesth Analg. 2002;94(2):378-84. table of contents. doi: 10.1097/00000539-200202000-00028. [PubMed: 11812703].
  • 29. Malyszko J, Lukaszyk E, Glowinska I, Durlik M. Biomarkers of delayed graft function as a form of acute kidney injury in kidney transplantation. Sci Rep. 2015;5:11684. doi: 10.1038/srep11684. [PubMed: 26175216]. [PubMed Central: PMC4502393].
  • 30. Aronson D, Mittleman MA, Burger AJ. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med. 2004;116(7):466-73. doi: 10.1016/j.amjmed.2003.11.014. [PubMed: 15047036].
  • 31. Simon D, Luke RG. Rate of rise of blood urea nitrogen in acute renal failure: Effect of acidosis. Proc Soc Exp Biol Med. 1971;137(3):1073-4. doi: 10.3181/00379727-137-35730. [PubMed: 5560654].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments